Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion type Assertion NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_head.
- NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion description "[We reported previously that angiogenesis evaluated by intratumor microvessel density (MVD), expression of such angiogenic factors as vascular endothelial cell growth factor (VEGF) and basic fibroblast growth factor (bFGF), and the matrix metalloproteinase-9:E-cadherin ratio (M:E ratio) could identify patients with advanced transitional cell carcinoma (TCC) of the bladder for whom chemotherapy and cystectomy will be unsuccessful.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_provenance.
- NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion evidence source_evidence_literature NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_provenance.
- NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion SIO_000772 12060629 NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_provenance.
- NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion wasDerivedFrom befree-20140225 NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_provenance.
- NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_assertion wasGeneratedBy ECO_0000203 NP804301.RA_5X0ybAc9i2wh_I-3HfSGKK9Fw1E-O9_xDLugkfjpe4130_provenance.